Clinvest Research

Springfield, Missouri 65810

1 studies enrolling now · 21 studies all time

What they study most

Aura Migraine, Cardiovascular Disease, Chronic Migraine, Chronic Migraine Without Aura, Chronic Migraine, Headache, Cluster Headache, Episodic, Diabetes Mellitus, Type 2, Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Obesity

Studies at this site

• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain — Recruiting now
• A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation — Running, not enrolling
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
• Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine — Completed
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes — Completed
• PArtial REbreathing for Migraine With Aura 1 — Stopped early
• A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine — Completed
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders — Stopped early
• A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine — Completed
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
• Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention — Completed
• Efficacy of Erenumab on Functional Impact of Migraine — Completed
• The MOTS (Medication Overuse Treatment Strategy) Trial — Completed
• A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine — Completed
• Evaluation of a Novel Device for Treatment of Migraine Headache — Completed
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes — Completed
• Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines — Completed
• A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine — Completed
• A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine — Completed
• A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) — Completed